X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-12 | MYO | Kirk Thomas F | Dir | P - Purchase | $3.35 | +50,000 | 305,933 | +20% | +$167,500 | ||||||
| A | 2025-03-14 | MYO | Mitchell Micah | Chief Commercial Officer | S - Sale | $5.16 | -48,000 | 140,269 | -25% | -$247,565 | |||||
2025-03-13 | MYO | Kirk Thomas F | Dir | P - Purchase | $5.00 | +7,400 | 255,933 | +3% | +$37,000 | ||||||
| A | 2025-03-14 | MYO | Mitchell Micah | Chief Commercial Officer | S - Sale | $5.16 | -48,000 | 140,572 | -25% | -$247,565 | |||||
2025-03-14 | MYO | Mitchell Micah | Chief Commercial Officer | S - Sale | $5.16 | -48,000 | 140,572 | -25% | -$247,565 | ||||||
2025-03-12 | MYO | Kovelman Harry | Chief Medical Officer | S - Sale | $5.50 | -30,000 | 96,477 | -24% | -$165,018 | ||||||
2024-09-05 | MYO | Kovelman Harry | Chief Medical Officer | S - Sale | $3.76 | -6,700 | 123,556 | -5% | -$25,183 | ||||||
2024-09-03 | MYO | Kovelman Harry | Chief Medical Officer | S - Sale | $4.01 | -2,029 | 130,256 | -2% | -$8,140 | ||||||
2024-05-29 | MYO | Kirk Thomas F | Dir | P - Purchase | $3.50 | +50,000 | 236,499 | +27% | +$175,000 | ||||||
2024-05-15 | MYO | Kovelman Harry | Chief Medical Officer | S - Sale | $3.69 | -35,426 | 98,009 | -27% | -$130,839 | ||||||
2024-03-14 | MYO | Kirk Thomas F | Dir | P - Purchase | $3.50 | +50,000 | 186,499 | +37% | +$175,000 | ||||||
2023-11-20 | MYO | Kirk Thomas F | Dir | P - Purchase | $3.10 | +50,000 | 136,499 | +58% | +$155,000 | ||||||
2023-12-08 | MYO | Crowley Thomas Aloysius Jr. | Dir | S - Sale | $0.00 | -14,997 | 29,994 | -33% | -$0 | ||||||
2023-12-01 | MYO | Kovelman Harry | Chief Medical Officer | S - Sale | $0.00 | -8,333 | 140,755 | -6% | -$0 | ||||||
2023-11-28 | MYO | Crowley Thomas Aloysius Jr. | Dir | S - Sale | $0.00 | -14,997 | 45,001 | -25% | -$0 | ||||||
2023-09-08 | MYO | Morris Milton Mayo | Dir | P - Purchase | $1.06 | +15,000 | 77,933 | +24% | +$15,867 | ||||||
2023-08-30 | MYO | Gudonis Paul R | CEO | P - Purchase | $0.74 | +48,400 | 878,245 | +6% | +$36,039 | ||||||
2023-08-29 | MYO | Kovelman Harry | Chief Medical Officer | P - Purchase | $0.60 | +8,333 | 149,556 | +6% | +$5,000 | ||||||
2023-08-29 | MYO | Henry David A | CFO | P - Purchase | $0.60 | +41,666 | 352,193 | +13% | +$25,000 | ||||||
| M | 2023-08-28 | MYO | Gudonis Paul R | CEO | P - Purchase | $0.76 | +79,500 | 829,845 | +11% | +$60,591 | |||||
| M | 2022-06-06 | MYO | Crowley Thomas Aloysius Jr. | Dir | S - Sale | $2.09 | -12,901 | 0 | -100% | -$26,953 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |